Corrado Cabona
Genoa, 16152, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A Consensus Clustering Approach to Amyotrophic Lateral Sclerosis Phenotyping.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Refining Electrophysiological Criteria in CIDP and MMN: Toward a Unified Definition of Motor Conduction Block and Proximal Temporal Dispersion.
Journal: European journal of neurology
Published: April 13, 2026
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses.
Journal: Frontiers in neurology
Published: July 04, 2025
Prevalence of cognitive impairment in motor neuron diseases: alternative norming methods lead to considerably diverse estimates.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: April 13, 2025
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy.
Journal: European journal of neurology
Published: April 11, 2025
Longitudinal respiratory trajectories in motor neuron disease phenotypes: Multiparametric characterization and clinical management.
Journal: Respiratory medicine
Published: December 05, 2024
Psychological resilience is protective against cognitive deterioration in motor neuron diseases.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 14, 2024
High-resolution ultrasound and superb microvascular imaging findings in a case of post-COVID-19 vaccine parsonage-turner syndrome with multiple nerves involvement.
Journal: Journal of clinical ultrasound : JCU
Published: July 15, 2024
Lacosamide-induced nodulocystic acne with keloid scarring.
Journal: Annales de dermatologie et de venereologie
Published: June 13, 2024
Dog-assisted physiotherapy in amyotrophic lateral sclerosis: a randomized controlled pilot study.
Journal: European journal of physical and rehabilitation medicine
Published: May 14, 2024
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.
Journal: PloS one
Published: April 17, 2024
Last Updated: 09/26/2026